| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2799155 | Diabetes Research and Clinical Practice | 2006 | 7 Pages |
Abstract
These results suggest that BBI therapy enhances preheparin LPL mass, accompanied by antiatherogenic changes in glucose and lipid metabolism.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Yoh Miyashita, Mariko Ebisuno, Masahiro Ohhira, Kei Endoh, Atsuhito Saiki, Nobukiyo Koide, Masaki Ohtsuka, Tomokazu Oyama, Kohji Shirai,